Latest information on COVID-19
Support teaching, research, and patient care.
Brief Biography: Stuart B. Goodman MD MSc PhD FRCSC FACS FBSE Stuart B. Goodman is the Robert L. and Mary Ellenburg Professor of Surgery, and Professor with Tenure in the Department of Orthopaedic Surgery at Stanford University. He has a courtesy appointment in the Department of Bioengineering, and is a Fellow of the Institute of Chemistry, Engineering and Medicine for Human Health (ChEM-H) at Stanford University. He was Chief of Orthopaedic Surgery at Stanford University from 1994-2002. Dr. Goodman received his BSc, MD and MSc (Institute of Medical Science) from the University of Toronto, and his PhD in Orthopedic Medical Science from Lund University in Sweden. He is a Fellow of the Royal College of Surgeons (Canada), the American Academy of Orthopaedic Surgeons and the American College of Surgeons. Dr. Goodman's clinical practice concentrates on adult reconstructive surgery. His clinical research interests center on the outcome of surgery for arthritis including primary and revision total joint replacement, juvenile arthritis, and osteonecrosis of the hip and knee. His basic science interests center on biocompatibility of orthopaedic implants, inflammation, and musculoskeletal tissue regeneration and repair. Dr. Goodman is/has been a member of numerous academic organizations including the AAOS Biological Implants Committee (Chairman), and is a former member of the AAOS Biomedical Engineering Committee. He is a member of the Hip Society, Knee Society and AAHKS, a consultant to the Orthopaedic and Rehabilitation Devices Advisory Panel of the FDA, and former vice-chairman of the Musculoskeletal Tissue Engineering study section at NIH. Dr. Goodman is on the editorial board of the Journal of Orthopaedic Research (Associate Editor), Clinical Orthopaedics (Associate Editor), Biomaterials (Associate Editor), Journal of Arthroplasty, Journal of Biomedical Materials Research, and other journals, and is a manuscript reviewer for over 30 journals in the fields of orthopaedic surgery, arthritis, bioengineering and biomaterials. Dr. Goodman has published over 500 peer-reviewed manuscripts in medical and bioengineering journals. Dr. Goodman and co-workers have received awards for their research from the Society for Biomaterials, Orthopaedic Research Society, the American Orthopaedic Association, Western Orthopaedic Association, and the Association of Bone and Joint Surgeons. Dr. Goodman was awarded the Clemson Award for Basic Research from the Society For Biomaterials in May 2000. He was the President of the Society For Biomaterials (2001-2) and served on the Board of Directors of the Orthopaedic Research Society. Dr. Goodman served as Co-Chair for the 1995, 2000 and 2007 NIH/AAOS-sponsored workshops on Implant Wear. Dr. Goodman was recognized as a Fellow, Biomaterials Science and Engineering (FBSE) by the International Union of Societies, Biomaterials Science and Engineering in May 2004, a Fellow of the Japanese Society of the Promotion of Science in 2011, and a Fellow of the American Institute of Medical and Biological Engineers in 2012.Dr. Goodman serves as a consultant for several companies including Hyalex,, Accelalox, Pluristem, and Wishbone Medical.
Orthopaedic Research Laboratories, Stanford University
As an academic orthopaedic surgeon, my interests center on adult reconstructive surgery including total joint replacement, osteotomies and the fixation of fractures. Both clinical and basic science investigations are ongoing. My specific research interests include the following:1. the biological aspects of the interface between orthopaedic implants/biomaterials and bone2. the innate immune system and macrophages 3. tissue engineering and mesenchymal tissue differentiation4. total joint replacement: prosthesis design, biomechanics, biomaterials, mechanisms of failure, imaging etc5. arthritis: etiology, diagnosis, imaging, treatment, outcomes6. osteonecrosis
Use of PET/MR Imaging in Chronic Pain
The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG)
to objectively identify and characterize pain generators in patients suffering from chronic
View full details